Preparation, characterization, and in vitro drug release behavior of thiolated alginate nanoparticles loaded budesonide as a potential drug delivery system toward inflammatory bowel diseases

References

• Kawadkar MJ, Ram A. Colon targeted chitosan microsphere compressed matrices for the treatment of ulcerative colitis - A. Pharm Rev. 2007;5(4).
   Google Scholar
• Melmed GY, Targan SR. Future biologic targets for IBD: potentials and pitfalls. Nat Rev Gastroenterol Hepatol. 2010;7(2):110–117.
   PubMed Web of Science ®Google Scholar
• Khor B, Gardet A, Xavier RJ. Genetics and pathogenesis of inflammatory bowel disease. Nature. 2011;474(7351):307–317.
   PubMed Web of Science ®Google Scholar
• Camma C, Giunta M, Rosselli M, et al. Mesalamine in the maintenance treatment of Crohn’s disease: a meta-analysis adjusted for confounding variables. Gastroenterology. 1997;113(5):1465–1473.
   PubMed Web of Science ®Google Scholar
• Jones ASC. Inflammatory bowel disease – drug treatment and its implications. Hosp Pharm. 2006;13:161–166.
   Google Scholar
• Taylor KM, Irving PM. Optimization of conventional therapy in patients with IBD. Nat Rev Gastroenterol Hepatol. 2011;8(11):646–656.
   PubMed Web of Science ®Google Scholar
• Isaacs KL, Lewis JD, Sandborn WJ, et al. State of the art: IBD therapy and clinical trials in IBD. Inflamm Bowel Dis. 2005;11(suppl_1):S3–S12.
   PubMedGoogle Scholar
• Dahan A, Amidon GL, Zimmermann EM. Drug targeting strategies for the treatment of inflammatory bowel disease: a mechanistic update. Expert Rev Clin Immunol. 2010;6(4):543–550.
   PubMed Web of Science ®Google Scholar
• Yang L, Chu JS, Fix JA. Colon-specific drug delivery: new approaches and in vitro/in vivo evaluation. Int J Pharm. 2002;235(1–2):1–15.
   PubMed Web of Science ®Google Scholar
• Arrick BA, Nathan CF. Glutathione metabolism as a determinant of therapeutic efficacy: a review. Cancer Res. 1984;44(10):4224–4232.
   PubMed Web of Science ®Google Scholar
• Hooper LV, Wong MH, Thelin A, et al. Molecular analysis of commensal host-microbial relationships in the intestine. Science. 2001;291(5505):881–884.
   PubMed Web of Science ®Google Scholar
• Stirrup V, Evans FD, Ledingham S, et al. Redox potential measurement in the gastrointestinal tract in man. Proceedings of the World Congress of Gastroenterology, Digestive Endoscopy, and Coloproctology; 1990 Aug 26–31; Sydney, Australia, 1990.
   Google Scholar
• Wilding IR, Davis SS, O’Hagan DT. Targeting of drugs and vaccines to the gut. Pharmacol Ther. 1994;62(1–2):97–124.
   PubMed Web of Science ®Google Scholar
• Hamidi M, Azadi A, Rafiei P. Hydrogel nanoparticles in drug delivery. Adv Drug Deliv Rev. 2008;60(15):1638–1649.
   PubMed Web of Science ®Google Scholar
• Sundar S, Kundu J, Kundu SC. Biopolymeric nanoparticles. Sci Technol Adv Mater. 2010;11(1):014104.
   PubMed Web of Science ®Google Scholar
• George M, Abraham TE. Polyionic hydrocolloids for the intestinal delivery of protein drugs: alginate and chitosan – a review. J Control Release. 2006;114(1):1–14.
   PubMed Web of Science ®Google Scholar
• Bernkop-Schnürch A, Kast CE, Richter MF. Improvement in the mucoadhesive properties of alginate by the covalent attachment of cysteine. J Control Release. 2001;71(3):277–285.
   PubMed Web of Science ®Google Scholar
• Bernkop-Schnürch A, Hornof M, Zoidl T. Thiolated polymers—thiomers: synthesis and in vitro evaluation of chitosan-2-iminothiolane conjugates. Int J Pharm. 2003;260(2):229–237.
   PubMed Web of Science ®Google Scholar
• Hombach J, Hoyer H, Bernkop-Schnürch A. Thiolated chitosans: development and in vitro evaluation of an oral tobramycin sulphate delivery system. Eur J Pharm Sci. 2008;33(1):1–8.
   PubMed Web of Science ®Google Scholar
• Coviello T, Matricardi P, Marianecci C, et al. Polysaccharide hydrogels for modified release formulations. J Control Release. 2007;119(1):5–24.
   PubMed Web of Science ®Google Scholar
• Gum JR, Hicks JW, Toribara NW, et al. The human MUC2 intestinal mucin has cysteine-rich subdomains located both upstream and downstream of its central repetitive region. J Biol Chem. 1992;267(30):21375–21383.
   PubMed Web of Science ®Google Scholar
• Marschütz MK, Caliceti P, Bernkop-Schnürch A. Design and in vivo evaluation of an oral delivery system for insulin. Pharm Res. 2000;17(12):1468–1474.
   PubMed Web of Science ®Google Scholar
• Mu B, Zhong W, Dong Y, et al. Encapsulation of drug microparticles with self-assembled Fe3O4/alginate hybrid multilayers for targeted controlled release. J Biomed Mater Res Part B Appl Biomater. 2012;100(3):825–831.
   PubMedGoogle Scholar
• Chang D, Lei J, Cui H, et al. Disulfide cross-linked nanospheres from sodium alginate derivative for inflammatory bowel disease: preparation, characterization, and in vitro drug release behavior. Carbohydr Polym. 2012;88(2):663–669.
   Web of Science ®Google Scholar
• Davidovich-Pinhas M, Harari O, Bianco-Peled H. Evaluating the mucoadhesive properties of drug delivery systems based on hydrated thiolated alginate. J Control Release. 2009;136(1):38–44.
   PubMed Web of Science ®Google Scholar
• Yu X, Pishko MV. Nanoparticle-based biocompatible and targeted drug delivery: characterization and in vitro studies. Biomacromolecules. 2011;12(9):3205–3212.
   PubMed Web of Science ®Google Scholar
• Gao C, Liu T, Dang Y, et al. pH/redox responsive core cross-linked nanoparticles from thiolated carboxymethyl chitosan for in vitro release study of methotrexate. Carbohydr Polym. 2014;111:964–970.
   PubMed Web of Science ®Google Scholar
• Gao C, Tang F, Zhang J, et al. Glutathione-responsive nanoparticles based on a sodium alginate derivative for selective release of doxorubicin in tumor cells. J Mater Chem B. 2017;5(12):2337–2346.
   PubMed Web of Science ®Google Scholar
• Sun Q, Luan L, Arif M, et al. Redox-sensitive nanoparticles based on 4-aminothiophenol-carboxymethyl inulin conjugate for budesonide delivery in inflammatory bowel diseases. Carbohydr Polym. 2018;189:352–359.
   PubMed Web of Science ®Google Scholar
• Sinha VR, Kumria R. Microbially triggered drug delivery to the colon. Eur J Pharm Sci. 2003;18(1):3–18.
   PubMed Web of Science ®Google Scholar
• Aslund F, Berndt KD, Holmgren A. Redox potentials of glutaredoxins and other thiol-disulfide oxidoreductases of the thioredoxin superfamily determined by direct protein-protein redox equilibria. J Biol Chem. 1997;272(49):30780–30786.
   PubMed Web of Science ®Google Scholar
• Finley JW, Wheeler EL, Witt SC. Oxidation of glutathione by hydrogen peroxide and other oxidizing agents. J Agric Food Chem. 1981;29(2):404–407.
   PubMed Web of Science ®Google Scholar
• Chawla JS, Amiji MM. Biodegradable poly(ε-caprolactone) nanoparticles for tumor-targeted delivery of tamoxifen. Int J Pharm. 2002;249(1–2):127–138.
   PubMed Web of Science ®Google Scholar
• Ijaz M, Bernkop-Schnürch A. Preactivated thiomers: their role in drug delivery. Expert Opin Drug Deliv. 2015;12(8):1269–1281.
   PubMed Web of Science ®Google Scholar